Kirin General Meeting of Shareholders Rejection of investment fund proposal, including sale of pharmaceutical business March 27 21:11
A major shareholder meeting of Kirin Holdings, a major beer company, was held, and all proposals by shareholders' UK investment funds to sell the pharmaceutical business were rejected.
Approximately 470 shareholders attended the General Meeting of Shareholders.
At a general meeting, Independent Franchise Partners, a UK investment fund holding approximately 2% of Kirin Holdings, will focus on the beer business, saying Kirin's diversification strategy has not led to the company's growth. I made a shareholder proposal to ask.
The proposal called for selling the business in the pharmaceutical and health fields, and then using the ¥ 600 billion obtained from the sale to buy back treasury stock that would lead to a rise in stock prices. Were both rejected.
After the General Assembly, Kirin Holdings President Issunori Isozaki said at a press conference, "Recognizing the importance of continuing to explain the legitimacy and effectiveness of management strategies to the market in response to the proposals, etc. We will continue to work with shareholders and stakeholders to meet their expectations. "